TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Lina Idrottsmedicin AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
161
|
164
|
170 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
20
|
25
|
44 |
EBITDA |
20
|
25
|
49 |
Total assets |
85
|
93
|
89 |
Current assets |
81
|
90
|
85 |
Current liabilities |
24
|
27
|
22 |
Equity capital |
54
|
61
|
63 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.5%
|
65.6%
|
70.8% |
Turnover per employee |
80
|
82
|
85 |
Profit as a percentage of turnover |
12.4%
|
15.2%
|
25.9% |
Return on assets (ROA) |
23.5%
|
26.9%
|
49.4% |
Current ratio |
337.5%
|
333.3%
|
386.4% |
Return on equity (ROE) |
37.0%
|
41.0%
|
69.8% |
Change turnover |
-4
|
8
|
18 |
Change turnover % |
-2%
|
5%
|
12% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.